NRO Neurones SA

Neurones: Net profit up 7.8% in 2024

Neurones: Net profit up 7.8% in 2024

PRESS INFORMATION

Heading: 2024 annual results        Nanterre, March 5, 2025 (after trading)

Net profit up 7.8% in 2024

Financial statements at December 31 (1)20232024
Revenues741.2810.4
Business operating profit (2)81.5 (11%)84.1 (10.4%)
Operating profit75.9 (10.2%)77.9 (9.6%)
Financial profit4.910.2
Tax on earnings(22.2)(24.9)
Net profit58.6 (7.9%)63.2 (7.8%)
- of which, group share49.452.5
Free cash flow (3)51.674.6
Cash and cash equivalents net of financial debt (4)290.4319.5
Staff at year-end6,7497,087

(1)        In millions of euros, 2024 financial statements approved by the Board of Directors on March 5, 2025.

(2)        Before cost of bonus shares

(3)        Cash flow from operational activities, plus financial profit/loss and less net industrial investments.

(4)        Excluding IFRS16 lease liabilities.

Achievements

NEURONES enjoyed another year of sustained growth in 2024 (+ 9.3%, of which + 8.6% organic compared with + 0.7% for the Consulting and Digital Services market), while net profit grew by 7.8%.

Free cash flow rose sharply, with a reduction in working capital requirement (- €8.5m) and capital expenditure (Capex) back to its usual level (€11.8m after €17.9m invested in the previous financial year, mainly in the Group's SecNumCloud sovereign and secure cloud platform).

Cash and cash equivalents at the end of the year rose to €319.5m (or €13 per share).

Outlook

As usual, forecasts for the current year will be posted along with the Group's 1st quarter revenues (on May 7, after the closing of the stock exchange). Driven by solid underlying trends (AI, cloud, cybersecurity, digital, data), NEURONES is well positioned to achieve another year of profitable growth.

At the Shareholders' Meeting on June 5, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year).

About NEURONES

With close to 7,200 experts, and ranking among the French leaders in consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) – Euronext Tech Leaders – DSS mid-caps – ‘PEA-PME’ eligible



Press Relations:

O'Connection

Julia Philippe-Brutin

Tel.: +33 (0)6 03 63 06 03









NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37



Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37



Attachment



EN
05/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

NEURONES: Organic growth up 5.1% in 3rd quarter 2025

NEURONES: Organic growth up 5.1% in 3rd quarter 2025 PRESS INFORMATIONHeading: 3rd quarter 2025 revenues        Nanterre, November 5, 2025 (after trading) Organic growth up 5.1% in 3rd quarter 2025 (not audited, in millions of euros)20242025growthof which organic3rd quarter revenues196.7207.9+ 5.7%+ 5.1%Total as at the end-September599.1632.2+ 5.5%+ 4.7% Achievements In a declining French market, NEURONES has continued its momentum in the third quarter, in line with the start of the year. Growth is particularly strong in the areas of Data & AI, digital projects, ITSM (Ser...

 PRESS RELEASE

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025 INFORMATION PRESSERubrique : C.A. 3e trimestre 2025        Nanterre, le 5 novembre 2025 (après Bourse) + 5,1% de croissance organique au 3e trimestre 2025 (non audités, en millions d’euros)20242025croissancedont organiqueChiffre d’affaires 3e trimestre196,7207,9+ 5,7%+ 5,1%Cumul à fin septembre599,1632,2+ 5,5%+ 4,7% Réalisations Dans un marché français en repli, NEURONES a poursuivi sa dynamique au 3e trimestre, dans la continuité du début de l’année. La croissance est particulièrement soutenue dans les domain...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (October 13 t...

NEURONES: Declaration of transactions on treasury shares (October 13 to 17, 2025) Nanterre, October 21, 2025 Declaration of transactions on treasury shares(period from 13 to 17 October 2025) As part of the share buyback program authorized by the General Meeting of June 5, 2025, NEURONES made the following purchases between October 13 and 17, 2025 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)10/16/202510,000€38.0510/17/2025      489€38.10Total10,489  As of October 17, 2025, excluding the liquidity contract, NEURONES now holds 10,489 ...

 PRESS RELEASE

NEURONES : Déclaration des transactions sur actions propres (période ...

NEURONES : Déclaration des transactions sur actions propres (période du 13 au 17 octobre 2025) Nanterre, le 21 octobre 2025 Déclaration des transactions sur actions propres(période du 13 au 17 octobre 2025) Dans le cadre du programme de rachat d’actions propres autorisé par l’Assemblée Générale du 5 juin 2025, NEURONES a procédé, entre le 13 et le 17 octobre 2025, aux achats suivants (code ISIN FR0004050250) : JourVolume total journalier(en nombre d'actions)Prix pondéré moyen(journalier unitaire)16/10/202510 00038,05 €17/10/2025      48938,10 €Total10 489  Au 17 octobre 2025, hors contra...

 PRESS RELEASE

NEURONES : Rapport financier premier semestre 2025

NEURONES : Rapport financier premier semestre 2025 NEURONES : Rapport financier premier semestre 2025 Pièce jointe

ResearchPool Subscriptions

Get the most out of your insights

Get in touch